相似文献
1
Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine.
Br J Cancer. 1990 Sep;62(3):372-5. doi: 10.1038/bjc.1990.300.
2
Endogenous tumor necrosis factor induction with Bordetella pertussis vaccine as a triggering agent and its therapeutic effect on MM46 carcinoma-bearing mice.
Jpn J Cancer Res. 1988 Mar;79(3):384-9. doi: 10.1111/j.1349-7006.1988.tb01602.x.
3
[The effect of endogenous tumor necrosis factor (TNF)-induction therapy in the model of VX-2 ovarian carcinoma in the rabbit].
Nihon Sanka Fujinka Gakkai Zasshi. 1990 Nov;42(11):1477-83.
4
Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.
J Biol Response Mod. 1990 Dec;9(6):564-9.
5
TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
J Biol Response Mod. 1988 Dec;7(6):596-607.
6
7
Effects of streptococcal preparation OK-432 on cytokine induction in spleen and tumour tissues of mice bearing MH-134 tumour cells.
J Int Med Res. 1999 Jan-Feb;27(1):27-37. doi: 10.1177/030006059902700104.
8
Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vaccine. 2007 Mar 8;25(12):2346-60. doi: 10.1016/j.vaccine.2005.09.062. Epub 2006 Dec 12.
9
[Induction of tumor necrosis factor (TNF) by OK-432].
Gan No Rinsho. 1984 Aug;30(10):1290-2.
10
Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.
Br J Cancer. 1994 Jun;69(6):1038-42. doi: 10.1038/bjc.1994.204.
引用本文的文献
1
Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.
Br J Cancer. 1994 Jun;69(6):1038-42. doi: 10.1038/bjc.1994.204.
本文引用的文献
1
The linear representation of dosage-response curves in microbial-antibiotic assays.
J Bacteriol. 1956 Jul;72(1):108-14. doi: 10.1128/jb.72.1.108-114.1956.
2
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
J Immunol. 1980 Oct;125(4):1671-7.
3
Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro.
Cancer. 1980 Feb;45(3):476-83. doi: 10.1002/1097-0142(19800201)45:3<476::aid-cncr2820450311>3.0.co;2-7.
4
Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Jpn J Cancer Res. 1985 Jul;76(7):631-6.
5
Endogenous production of TNF in mice with immune complex as a primer.
J Biol Response Mod. 1986 Apr;5(2):140-7.
6
[Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor].
Gan To Kagaku Ryoho. 1987 Jul;14(7):2378-80.
7
Endogenous production of TNF in mice long after BCG sensitization.
J Biol Response Mod. 1986 Apr;5(2):117-23.
8
Local induction of a tumor necrosis factor (TNF)-like cytotoxic factor in murine tissues with tumorous and nontumorous inflammation after systemic administration of antitumor polysaccharides.
J Pharmacobiodyn. 1988 Jul;11(7):472-8. doi: 10.1248/bpb1978.11.472.
9
Endogenous tumor necrosis factor induction with Bordetella pertussis vaccine as a triggering agent and its therapeutic effect on MM46 carcinoma-bearing mice.
Jpn J Cancer Res. 1988 Mar;79(3):384-9. doi: 10.1111/j.1349-7006.1988.tb01602.x.
10
Anti-tumour therapy by induction of endogenous tumour necrosis factor.
Lancet. 1985 Aug 3;2(8449):270. doi: 10.1016/s0140-6736(85)90312-5.
Zotero 插件